Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01844505 |
|---|---|
| Brief Title: | Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067) |
| First Submitted : | April 29, 2013 |
| First Submitted that Met QC Criteria : | April 30, 2013 |
| First Posted : | May 1, 2013 (Estimate) |
| Results First Submitted : | July 14, 2017 |
| Results First Submitted that Met QC Criteria : | August 28, 2017 |
| Results First Posted : | September 26, 2017 |
| Last Update Submitted that Met QC Criteria : | January 5, 2024 |
| Last Update Posted : | January 10, 2024 |